NO20082354L - Nye sykliske forbindelser - Google Patents

Nye sykliske forbindelser

Info

Publication number
NO20082354L
NO20082354L NO20082354A NO20082354A NO20082354L NO 20082354 L NO20082354 L NO 20082354L NO 20082354 A NO20082354 A NO 20082354A NO 20082354 A NO20082354 A NO 20082354A NO 20082354 L NO20082354 L NO 20082354L
Authority
NO
Norway
Prior art keywords
hepatitis
cyclic compounds
new cyclic
virus
replication
Prior art date
Application number
NO20082354A
Other languages
English (en)
Norwegian (no)
Inventor
Masahiro Neya
Seiji Yoshimura
Kazunori Kamijyo
Takuya Makino
Minoru Yasuda
Toshio Yamanaka
Eisaku Tsujii
Yukiko Yamagishi
Original Assignee
Astellas Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astellas Pharma Inc filed Critical Astellas Pharma Inc
Publication of NO20082354L publication Critical patent/NO20082354L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C07K7/645—Cyclosporins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NO20082354A 2005-10-26 2008-05-23 Nye sykliske forbindelser NO20082354L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US73001105P 2005-10-26 2005-10-26
US75120405P 2005-12-19 2005-12-19
PCT/JP2006/321924 WO2007049803A1 (en) 2005-10-26 2006-10-26 New cyclic peptide compounds

Publications (1)

Publication Number Publication Date
NO20082354L true NO20082354L (no) 2008-07-01

Family

ID=37847219

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20082354A NO20082354L (no) 2005-10-26 2008-05-23 Nye sykliske forbindelser

Country Status (17)

Country Link
US (2) US7872097B2 (enExample)
EP (1) EP1957518B1 (enExample)
JP (1) JP5218051B2 (enExample)
KR (1) KR101273681B1 (enExample)
CN (1) CN101305019B (enExample)
AU (1) AU2006306974B2 (enExample)
BR (1) BRPI0617781A2 (enExample)
CA (1) CA2623898C (enExample)
ES (1) ES2557477T3 (enExample)
IL (1) IL190286A0 (enExample)
NO (1) NO20082354L (enExample)
PL (1) PL1957518T3 (enExample)
PT (1) PT1957518E (enExample)
RU (1) RU2423377C2 (enExample)
TW (1) TWI391403B (enExample)
WO (1) WO2007049803A1 (enExample)
ZA (1) ZA200803525B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2150269B1 (en) * 2007-05-02 2012-11-21 Astellas Pharma Inc. New cyclic peptide compounds
MX2011003259A (es) * 2008-09-24 2011-04-21 Astellas Pharma Inc Compuesto de peptido y metodo para producir el mismo.
RU2492181C2 (ru) * 2009-01-30 2013-09-10 Энанта Фармасьютикалс, Инк. Аналоги циклоспорина для предупреждения или лечения инфекции гепатита с
US8481483B2 (en) 2009-02-19 2013-07-09 Enanta Pharmaceuticals, Inc. Cyclosporin analogues
CN102459160A (zh) * 2009-05-15 2012-05-16 荷兰癌症研究所基金会 赖氨酸化合物和其在肽和蛋白质的位点选择性和化学选择性修饰中的用途
US8367053B2 (en) 2009-07-09 2013-02-05 Enanta Pharmaceuticals, Inc. Cyclosporin analogues
US8349312B2 (en) 2009-07-09 2013-01-08 Enanta Pharmaceuticals, Inc. Proline substituted cyclosporin analogues
US8685917B2 (en) 2009-07-09 2014-04-01 Enanta Pharmaceuticals, Inc. Cyclosporin analogues
CA2785978A1 (en) * 2009-12-30 2011-07-07 Scynexis, Inc. Cyclosporine analogues
JP2015529206A (ja) 2012-08-25 2015-10-05 ザ・ジョンズ・ホプキンス・ユニバーシティ Gapdhカスケードインヒビター化合物ならびに使用の方法および精神病を含むストレス誘導障害の処置
WO2014049540A2 (en) 2012-09-29 2014-04-03 Novartis Ag Cyclic peptides and use as medicines
US8906853B2 (en) 2012-11-28 2014-12-09 Enanta Pharmaceuticals, Inc. [N-Me-4-hydroxyleucine]-9-cyclosporin analogues for treatment and prevention of hepatitis C infection
HK1223843A1 (zh) * 2013-08-26 2017-08-11 Enanta Pharmaceuticals, Inc. 用於預防或治療丙型肝炎的環孢菌素類似物
US9669095B2 (en) 2014-11-03 2017-06-06 Enanta Pharmaceuticals, Inc. Cyclosporin analogues for preventing or treating hepatitis C infection

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05271267A (ja) * 1991-04-23 1993-10-19 Fujisawa Pharmaceut Co Ltd Fr901459物質、その製法及び用途
PT1091975E (pt) 1998-07-01 2006-05-31 Debiopharm Sa Nova ciclosporina com um perfil de actividade melhorado
CA2426381A1 (en) 2000-10-19 2002-04-25 Fujisawa Pharmaceutical Co., Ltd. Cell damage inhibitor
DK1436322T3 (da) * 2001-10-19 2008-11-03 Isotechnika Inc Blandinger af cyclosporinanaloger og deres anvendelse som immunmodulerende midler
GB0320638D0 (en) * 2003-09-03 2003-10-01 Novartis Ag Organic compounds
JP2007015926A (ja) * 2003-10-06 2007-01-25 Fujisawa Pharmaceut Co Ltd C型肝炎治療剤
PT1802650E (pt) 2004-10-01 2011-12-30 Scynexis Inc Derivados da ciclosporina 3-éter e 3-tioéter substituída para o tratamento e prevenção da infecção de hepatite c
ATE490778T1 (de) 2004-10-01 2010-12-15 Debiopharm Sa Verwendung von äd-mealaü3-äetvalü4-ciclosporin zur behandlung von hepatitis-c-infektion
ES2314731T3 (es) * 2004-11-22 2009-03-16 Astellas Pharma Inc. Analogo de ciclosporina.

Also Published As

Publication number Publication date
EP1957518A1 (en) 2008-08-20
EP1957518B1 (en) 2015-12-09
JP2009513562A (ja) 2009-04-02
RU2423377C2 (ru) 2011-07-10
CA2623898A1 (en) 2007-05-03
PL1957518T3 (pl) 2016-07-29
AU2006306974B2 (en) 2011-09-22
CN101305019B (zh) 2012-12-12
ES2557477T3 (es) 2016-01-26
PT1957518E (pt) 2016-02-26
US7872097B2 (en) 2011-01-18
CA2623898C (en) 2013-12-24
TW200732351A (en) 2007-09-01
KR101273681B1 (ko) 2013-06-25
KR20080065297A (ko) 2008-07-11
TWI391403B (zh) 2013-04-01
ZA200803525B (en) 2009-08-26
AU2006306974A1 (en) 2007-05-03
RU2008116674A (ru) 2009-10-27
US20090170755A1 (en) 2009-07-02
JP5218051B2 (ja) 2013-06-26
US20100286033A1 (en) 2010-11-11
US8252895B2 (en) 2012-08-28
BRPI0617781A2 (pt) 2011-08-09
WO2007049803A1 (en) 2007-05-03
CN101305019A (zh) 2008-11-12
IL190286A0 (en) 2011-08-01

Similar Documents

Publication Publication Date Title
ATE411280T1 (de) Phenoxyessigsäure-derivate zur behandlung von störungen der atemwege
DE60314495D1 (de) Aminosäuresequenzen die die fähigkeit besitzen, die durchdringung durch eine biologische barriere erleichtern
CY1112115T1 (el) Παραγωγα φαινοξυοξικου οξεος χρησιμα για τη θεραπευτικη αντιμετωπιση ασθενειων του αναπνευστικου
CY1110812T1 (el) Παραγωγα διφαινυλοξυοξικου οξεος για τη θεραπεια αναπνευστικων διαταραχων
BRPI0718586A2 (pt) Composto, processo para a sua preparação, composição farmacêutica contendo o mesmo, usos deste e método de tratamento ou prevenção de doenças
NO20080745L (no) Nye peptider for anvendelse i behandling av fedme
SE0301010D0 (sv) Novel compounds
DE60323090D1 (de) 1h-imidazoä4,5-cüchinolinderivate zur behandlung von protein kinase-abhängigen krankheiten
TW200732351A (en) New cyclic peptide compounds
NO20072290L (no) Organiske forbindelser.
WO2005002526A3 (en) Method and compositions for treatment of viral infections
WO2006034373A3 (en) Variants and chemically-modified variants of phenylalanine ammonia-lyase
BRPI0416287A (pt) compostos, processo para a manufatura dos mesmos, composições farmacêuticas que os compreendem, método para o tratamento e/ou prevenção de enfermidades que são moduladas por inibidores de accß e sua utilização
BRPI0513819A (pt) inibidores de hsp90
DE502004008819D1 (de) Medikament zur wachstumsinhibierung von tumoren
NO20081681L (no) N-[1,3,4]-tiadiazol-2-yl-benzensulfonamider, fremgangsmate for fremstilling derav og deres anvendelse som farmasoytika
NO20070665L (no) Derivater av 1-fenylalkankarboksylsyrer for behandlingen av neurodegenerative sykdommer
TW200510352A (en) Cycloalkyl substituted amino acid derivatives, processes for their freparation and their use as pharmaceuticals
BRPI0415781A (pt) método para o tratamento de diabetes em um paciente e kit farmacêutico
ATE508749T1 (de) Antidepressiva zur prophylaxe und therapie von zystischer fibrose
BRPI0911159A2 (pt) compostos derivados de ácido 4-dimetilaminobutírico, processo para a sua preparação, composições farmacêuticas que os compreendem, método para o tratamento terapêutico ou profilático de enfermidades que são moduladas por inibidres de cpt2 e uso destes compostos
NO20081675L (no) Cykliske N-[1,3,4]-tiadiazol-2-yl-benzensulfonamlder, fremgangsmate for fremstilling derav og deres anvendelse som farmasoytika
WO2007076091A3 (en) Treatment of viral infections using a tissue factor inhibitor
NO20052172L (no) 4-aminopiperidinderivater, fremgangsmate for deres fremstilling og deres anvendelse som medikamenter
BRPI0512951A (pt) compostos, processo para sua fabricação, composições farmacêuticas contendo os mesmos, uso e método para tratamento e/ou prevenção de doenças que são moduladas pelos agonistas de ppar(delta) e/ou ppar(alpha)

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application